“Our findings suggested that hesperetin and naringenin enhanced the systemic exposure of rasagiline might be through the inhibition of CYP1A2 but not P-gp.”
“ Rasagiline concentrations were significantly increased when co-administered with hesperetin and naringenin in the brain.”